The CBD Conundrum at the FDA

Should cannabidiol be regulated as a supplement, or a drug? Is it effective? Safe? Big business waits impatiently in the wings as the agency thinks through decisions to shape a multi-billion-dollar industry.

CBD
Congress, Newsletter

Outgoing Rep. Blumenauer Talks Banking, Hemp, and Trump

An excerpt from the Cannabis Wire Daily newsletter.

Newsletter, Regulation

Who’s Calling for a Hearing on Rescheduling?

An excerpt from the Cannabis Wire Daily newsletter.